|
|
|
Volumn 19, Issue SUPPL. P, 1998, Pages
|
|
Health economic consequences of the pharmacological treatment of heart failure
|
|
Author keywords
Epidemiology; Health economics; Health services; Heart failure
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL;
CARVEDILOL;
CHOLESTEROL;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
HYDRALAZINE;
INOTROPIC AGENT;
ISOSORBIDE DINITRATE;
RAMIPRIL;
STATIN;
TRANDOLAPRIL;
CLINICAL TRIAL;
CONFERENCE PAPER;
COST EFFECTIVENESS ANALYSIS;
HEALTH CARE COST;
HEALTH ECONOMICS;
HEART FAILURE;
HUMAN;
HYPERCHOLESTEROLEMIA;
LIFE EXPECTANCY;
PRIORITY JOURNAL;
RESOURCE MANAGEMENT;
REVASCULARIZATION;
SURVIVAL;
VASCULAR DISEASE;
COST-BENEFIT ANALYSIS;
HEART FAILURE, CONGESTIVE;
HUMANS;
|
|
EID: 0031732326
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (42)
|
|
References (53)
|
